Wolfe Research analyst Mike Polark reiterated a Peerperform rating on Silk Road Medical (NASDAQ: SILK).The analyst comments "We rate SILK ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE